Journal of Pharmacy And Bioallied Sciences
Journal of Pharmacy And Bioallied Sciences Login  | Users Online: 136  Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size 
    Home | About us | Editorial board | Search | Ahead of print | Current Issue | Past Issues | Instructions | Online submission


    Article Cited by others

ORIGINAL ARTICLE

Pharmacological evaluation of novel 5-HT 3 receptor antagonist, QCM-13 (N-cyclohexyl-3-methoxyquinoxalin-2-carboxamide) as anti-anxiety agent in behavioral test battery

Gupta Deepali, Radhakrishnan Mahesh, Thangaraj Devadoss, Kurhe Yeshwant

Year : 2015| Volume: 7| Issue : 2 | Page no: 103-108

   This article has been cited by
 
1 Single Administration of HBK-15—a Triple 5-HT1A, 5-HT7, and 5-HT3 Receptor Antagonist—Reverses Depressive-Like Behaviors in Mouse Model of Depression Induced by Corticosterone
Karolina Pytka,Monika Gluch-Lutwin,Magdalena Kotanska,Anna Waszkielewicz,Agnieszka Kij,Maria Walczak
Molecular Neurobiology. 2017;
[Pubmed]  [Google Scholar] [DOI]
2 Drug delivery systems for fluoroquinolones: New prospects in tuberculosis treatment
I. M. Le-Deygen,A. A. Skuredina,E. V. Kudryashova
Russian Journal of Bioorganic Chemistry. 2017; 43(5): 487
[Pubmed]  [Google Scholar] [DOI]
3 The anxiolytic- and antidepressant-like effects of ATPM-ET, a novel ? agonist and µ partial agonist, in mice
Qian Wang,Yu Long,Ai Hang,Gui-Ying Zan,Xiao-Hong Shu,Yu-Jun Wang,Jing-Gen Liu
Psychopharmacology. 2016; 233(12): 2411
[Pubmed]  [Google Scholar] [DOI]
4 Concordance and incongruence in preclinical anxiety models: Systematic review and meta-analyses
Farhan Mohammad,Joses Ho,Jia Hern Woo,Chun Lei Lim,Dennis Jun Jie Poon,Bhumika Lamba,Adam Claridge-Chang
Neuroscience & Biobehavioral Reviews. 2016;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article